Back to Results
First PageMeta Content
Anticoagulants / Ketones / Vitamin K antagonists / Coagulation system / Rivaroxaban / Dabigatran / Warfarin / Factor X / Coagulation / Chemistry / Organic chemistry / Hematology


Microsoft Word[removed]Pharmacotherapeutic report on rivaroxaban _Xarelto_ for the indication .Prevention of CVA and systemic em
Add to Reading List

Document Date: 2013-06-26 04:38:36

Open Document

File Size: 66,58 KB

Share Result on Facebook

Company

ITT / /

IndustryTerm

medicinal products / /

MedicalCondition

pulmonary embolism / intracranial hemorrhage / systemic embolism / congestive heart failure / cerebrovascular accident / hypertension / diabetes mellitus / deep vein thrombosis / venous thromboembolism / /

MedicalTreatment

knee replacement surgery / hip surgery / /

Organization

Medicinal Products Reimbursement Committee / /

Product

vitamin K / Registered / /

URL

www.cvz.nl / /

SocialTag